|
1
|
Shapiro WR and Shapiro JR: Biology and
treatment of malignant glioma. Oncology (Williston Park).
12:233–240. 1998.PubMed/NCBI
|
|
2
|
Preusser M, Haberler C and Hainfellner JA:
Malignant glioma: Neuropathology and neurobiology. Wien Med
Wochenschr. 156:332–337. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang B, Li M, Wu Z, Li X, Li Y, Shi X and
Cheng W: Associations between SOX2 and miR-200b expression with the
clinicopathological characteristics and prognosis of patients with
glioma. Exp Ther Med. 10:88–96. 2015.PubMed/NCBI
|
|
4
|
Wong ML, Kaye AH and Hovens CM: Targeting
malignant glioma survival signalling to improve clinical outcomes.
J Clin Neurosci. 14:301–308. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qi J, Yang H, Wang X and Tu Y: The
progress in molecular biomarkers of gliomas. Cancer Transl Med.
2:125–129. 2016. View Article : Google Scholar
|
|
6
|
Rizzo D, Ruggiero A, Martini M, Rizzo V,
Maurizi P and Riccardi R: Molecular biology in pediatric high-grade
glioma: Impact on prognosis and treatment. Biomed Res Int.
2015:2151352015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun R, Li J, Wang B, Guo Y, Ma L, Quan X,
Chu Z and Li T: Liver kinase B1 promoter CpG island methylation is
related to lung cancer and smoking. Int J Clin Exp Med.
8:14070–14074. 2015.PubMed/NCBI
|
|
8
|
Rhodes LV, Tate CR, Hoang VT, Burks HE,
Gilliam D, Martin EC, Elliott S, Miller DB, Buechlein A, Rusch D,
et al: Regulation of triple-negative breast cancer cell metastasis
by the tumor-suppressor liver kinase B1. Oncogenesis. 4:e1682015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Peng DY, Song H and Liu LB:
Resveratrol-downregulated phosphorylated liver kinase B1 is
involved in senescence of acute myeloid leukemia stem cells. J
Huazhong Univ Sci Technolog Med Sci. 35:485–489. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rao F, Xu J, Fu C, Cha JY, Gadalla MM, Xu
R, Barrow JC and Snyder SH: Inositol pyrophosphates promote tumor
growth and metastasis by antagonizing liver kinase B1. Proc Natl
Acad Sci USA. 112:1773–1778. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xia C, Ye F, Hu X, Li Z, Jiang B, Fu Y,
Cheng X, Shao Z and Zhuang Z: Liver kinase B1 enhances
chemoresistance to gemcitabine in breast cancer MDA-MB-231 cells.
Oncol Lett. 8:2086–2092. 2014.PubMed/NCBI
|
|
12
|
Godlewski J, Bronisz A, Nowicki MO,
Chiocca EA and Lawler S: microRNA-451: A conditional switch
controlling glioma cell proliferation and migration. Cell Cycle.
9:2742–2748. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang YS, Lei JA, Feng F, Liang QM and
Wang FR: Probucol suppresses human glioma cell proliferation in
vitro via ROS production and LKB1-AMPK activation. Acta Pharmacol
Sin. 35:1556–1565. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vigneswaran K, Neill S and Hadjipanayis
CG: Beyond the world health organization grading of infiltrating
gliomas: Advances in the molecular genetics of glioma
classification. Ann Transl Med. 3:952015.PubMed/NCBI
|
|
15
|
Ballester M, Castelló A, Ibáñez E, Sánchez
A and Folch JM: Real-time quantitative PCR-based system for
determining transgene copy number in transgenic animals.
Biotechniques. 37:610–613. 2004.PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C (T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu J, Sun P, Sun B and Wang C: Low LKB1
expression results in unfavorable prognosis in prostate cancer
patients. Med Sci Monit. 21:3722–3727. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Momcilovic M, McMickle R, Abt E, Seki A,
Simko SA, Magyar C, Stout DB, Fishbein MC, Walser TC, Dubinett SM
and Shackelford DB: Heightening energetic stress selectively
targets LKB1-deficient non-small cell lung cancers. Cancer Res.
75:4910–4922. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gan RY and Li HB: Recent progress on liver
kinase B1 (LKB1): Expression, regulation, downstream signaling and
cancer suppressive function. Int J Mol Sci. 15:16698–16718. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Momcilovic M and Shackelford DB: Targeting
LKB1 in cancer-exposing and exploiting vulnerabilities. Br J
Cancer. 113:574–584. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou W, Zhang J and Marcus AI: LKB1 Tumor
Suppressor: Therapeutic opportunities knock when LKB1 is
inactivated. Genes Dis. 1:64–74. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Monteverde T, Muthalagu N, Port J and
Murphy DJ: Evidence of cancer-promoting roles for AMPK and related
kinases. FEBS J. 282:4658–4651. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang YH, Chen ZK, Huang KT, Li P, He B,
Guo X, Zhong JQ, Zhang QY, Shi HQ, Song QT, et al: Decreased
expression of LKB1 correlates with poor prognosis in hepatocellular
carcinoma patients undergoing hepatectomy. Asian Pac J Cancer Prev.
14:1985–1988. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
He TY, Tsai LH, Huang CC, Chou MC and Lee
H: LKB1 loss at transcriptional level promotes tumor malignancy and
poor patient outcomes in colorectal cancer. Ann Surg Oncol.
21:(Suppl 4) S703-S710. 2014. View Article : Google Scholar
|
|
25
|
Yang JY, Jiang SH, Liu DJ, Yang XM, Huo
YM, Li J, Hua R, Zhang ZG and Sun YW: Decreased LKB1 predicts poor
prognosis in Pancreatic Ductal Adenocarcinoma. Sci Rep.
5:105752015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shen Z, Wen XF, Lan F, Shen ZZ and Shao
ZM: The tumor suppressor gene LKB1 is associated with prognosis in
human breast carcinoma. Clin Cancer Res. 8:2085–2090.
2002.PubMed/NCBI
|
|
27
|
Jiang L, Liang X, Liu M, Wang W, Ma J, Guo
Q, Han L, Yang C and Nan K: Reduced expression of liver kinase B1
and Beclin1 is associated with the poor survival of patients with
non-small cell lung cancer. Oncol Rep. 32:1931–1958.
2014.PubMed/NCBI
|
